Abstract:OBJECTIVE To develop an ultra-performance liquid chromatography-tandem mass spectrometry（UPLC-MS/MS）method for determination of polymyxin B in plasma.METHODS The analytical column was ACQUITY UPLC HSS T3 column（2.1 mm×100 mm, 1.7 μm）.The mobile phase consisted of aqueous phase A as water and organic phase B composed of methanol and acetonitrile（1∶1,V/V）.Formic acid in all mobile phase was adjusted to 0.2%.The gradient elution lasted 3.5 mins.Electron spray ionization was set at positive mode.Multiple reaction monitoring was performed at m/z 602.4→241.1 for PB1,595.5→100.9 for PB2 and 585.5→202.0 for internal standard PE1.According to one compartment model, trough and peak plasma concentration were obtained to calculate AUC ss, 24h .RESULTS The linear range of PB1 in plasma was 0.05-5 μg·mL -1 and PB2 was 0.015-0.372 μg·mL -1 .The intra-day and inter-day precision were less than 10.9%,and the accuracy was between 88.8% and 105.7%.For the average recoveries was 88.0% to 103.2%,and the matrix effect was 100.0% to 113.7%.The analyte was stable when the plasma samples were stored at room temperature for 6 h, at 4 ℃ for 24 h, after 3 freeze-thaw cycles and-80 ℃ for 30 days.By empirical medication one of six patients included in the observation had an AUC ss, 24h lower than 50 mg·h·L -1 ,which was reported to doctors immediately and after dosage optimization AUC ss, 24h met requirements.CONCLUSION The established UPLC-MS/MS method was rapid, accurate, sensitive and specific and was successfully used to monitor major polymyxin B.The method validation is in according with guidelines for biological samples quantitative analysis.Our method is suitable for polymyxin B therapeutic drug monitoring in clinical practice.

Determination of plasma protein binding rate of methyl protodioscin with ultrafiltration

Determination of plasma protein binding rate of protoapigenone form Macrothelypteris torresiana

Determination of plasma protein binding rate of tetramethylpyrazine-nitrone derivative MPI-01 by rectified ultrafiltration

Determination of the Content of Methyl Protodioscin by HPLC

Development and validation of a liquid chromatography/tandem mass spectrometry assay for the quantification of methyl protodioscin in rat plasma: application to a pharmacokinetic study.

A New Quantitation Method of Protodioscin by HPLC–ESI-MS/MS in Rat Plasma and Its Application to the Pharmacokinetic Study

Determination of plasma protein binding of ponicidin by ultrafiltration

Determination of plasma protein binding rate of harmine hydrochloride

Determination of Binding Rate of Trimetazidine and Human Plasma Protein

Determination of Pseudoprotodioscin in Rat Plasma by UPLC–MS/MS: Assay Development and Application to Pharmacokinetic Study

Determination of Plasma,Gastrointestinal Content and Mucosa Concentrafion of Ketoprofen in Rats by HPLC

Analysis of Methyl Protodioscin Metabolites in Rats after Intravenous Administration by Liquid Chromatography Tandem Mass Spectrometry

Determination of Plasma Protein Binding Rate of Deoxyschisandrin at 4 ℃

Pharmacokinetics of Methyl Protodioscin in Rats

Simultaneous Determination of 20(S)-Protopanaxadiol and Its Three Metabolites in Rat Plasma by LC-MS/MS: Application to Their Pharmacokinetic Studies.

HPLC determination of polydatin in rat biological matrices: application to pharmacokinetic studies.

Determination of polymyxin B in plasma by UPLC-MS/MS and dosage optimization

Assay of in Vitro Plasma Protein Binding Rate of Mangiferin in Rats

Determination of S-propargyl-cysteine in rat plasma by mixed-mode reversed-phase and cation-exchange HPLC-MS/MS method and its application to pharmacokinetic studies.

Structural identification of methyl protodioscin metabolites in rats' urine and their antiproliferative activities against human tumor cell lines.

A sensitive method for determination of platycodin d in rat plasma using liquid chromatography/tandem mass spectrometry and its application to a pharmacokinetic study.